MRI Bone Texture: A Novel Biomarker for Assessment of Bone Quality and Prediction of Complications in Patients Having Spine Fusion Surgery

MRI 骨纹理:一种用于评估脊柱融合手术患者骨质量和预测并发症的新型生物标志物

基本信息

  • 批准号:
    10518526
  • 负责人:
  • 金额:
    $ 17.64万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2022
  • 资助国家:
    美国
  • 起止时间:
    2022-08-01 至 2026-05-31
  • 项目状态:
    未结题

项目摘要

Project Summary Spine fusion surgery is one of the most common, and complex, orthopedic procedures. Complications occur in over 30% of cases, highlighting the need to identify modifiable factors associated with these negative sequelae. Bone quality is a critical determinant of post-operative outcomes, as stability of hardware in bone and de novo bone formation are required for successful fusion. Despite the importance of bone quality to post-operative outcomes, there are limited tools for pre-operative detection of abnormal bone in candidates for fusion. The most common clinical tool for skeletal assessment, dual energy x-ray absorptiometry (DXA), is subject to artifact from spinal abnormalities and infrequently performed for pre-operative evaluation. High resolution peripheral QCT (HRpQCT) can detect pre-operative skeletal abnormalities and predict complications after fusion but is a research tool not available in clinical practice. In contrast, MRI is routinely performed prior to fusion, for diagnosis of spinal disease and surgical planning, making an MRI-based technique ideal to screen for pre-operative skeletal deficits. Our group has recently developed a novel method to evaluate bone quality using standard, clinically acquired MRIs which analyzes the irregularity, or heterogeneity, of trabecular bone texture. In prior work, we found that postmenopausal women with fractures had greater heterogeneity of bone texture than age- matched controls. The proposed study will assess MRI trabecular bone texture as a new technique to detect poor bone quality, predict complications, and track post-operative skeletal changes in patients undergoing spinal fusion. We hypothesize that pre-operative MRI bone texture will relate to volumetric BMD (vBMD) and microarchitecture by HRpQCT and will predict skeletal complications after surgery. Post-operative changes in MRI bone texture will relate to baseline patient characteristics and clinical post-operative treatment regimen, including use of anabolic agents. We will prospectively enroll 100 patients having lumbar spine fusion and follow them for one year. Baseline DXA, HRpQCT, and our MRI-based method will be performed. MRIs will be repeated at 6 months post-operatively to determine whether early changes in MRI bone texture relate to patient characteristics, medication use, and predict complications. CT scans will be performed at one year to assess skeletal complications and completeness of fusion. This proposal aims to: 1) Investigate the relationship between pre-operative MRI bone texture and HRpQCT measurements of vBMD and microarchitecture; 2) Investigate whether MRI bone texture predicts skeletal complications after fusion; 3) Assess longitudinal changes in bone texture and the clinical factors that influence these changes in patients after spine fusion. The long-term goals of our research are to improve identification of patients at high risk for post-operative complications and provide knowledge that will advance future interventional trials. In subsequent work, we plan to extend this technique to other orthopedic populations. Ultimately, we hope to improve the outcomes of patients undergoing fusion and other high-risk orthopedic surgeries by facilitating the creation of new peri-operative treatment paradigms.
项目总结

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Emily Margaret Stein其他文献

Emily Margaret Stein的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Emily Margaret Stein', 18)}}的其他基金

MRI Bone Texture: A Novel Biomarker for Assessment of Bone Quality and Prediction of Complications in Patients Having Spine Fusion Surgery
MRI 骨纹理:一种用于评估脊柱融合手术患者骨质量和预测并发症的新型生物标志物
  • 批准号:
    10669274
  • 财政年份:
    2022
  • 资助金额:
    $ 17.64万
  • 项目类别:
Chronic Kidney Disease and PTH: Effects on the Postmenopausal Skeleton
慢性肾脏病和 PTH:对绝经后骨骼的影响
  • 批准号:
    8521265
  • 财政年份:
    2009
  • 资助金额:
    $ 17.64万
  • 项目类别:
Chronic Kidney Disease and PTH: Effects on the Postmenopausal Skeleton
慢性肾脏病和 PTH:对绝经后骨骼的影响
  • 批准号:
    7911704
  • 财政年份:
    2009
  • 资助金额:
    $ 17.64万
  • 项目类别:
Chronic Kidney Disease and PTH: Effects on the Postmenopausal Skeleton
慢性肾脏病和 PTH:对绝经后骨骼的影响
  • 批准号:
    8311824
  • 财政年份:
    2009
  • 资助金额:
    $ 17.64万
  • 项目类别:
Chronic Kidney Disease and PTH: Effects on the Postmenopausal Skeleton
慢性肾脏病和 PTH:对绝经后骨骼的影响
  • 批准号:
    8129509
  • 财政年份:
    2009
  • 资助金额:
    $ 17.64万
  • 项目类别:
Chronic Kidney Disease and PTH: Effects on the Postmenopausal Skeleton
慢性肾脏病和 PTH:对绝经后骨骼的影响
  • 批准号:
    7714741
  • 财政年份:
    2009
  • 资助金额:
    $ 17.64万
  • 项目类别:

相似海外基金

The role of osteoblast progenitors in response to bone anabolic agents
成骨细胞祖细胞对骨合成代谢剂的反应的作用
  • 批准号:
    10404415
  • 财政年份:
    2023
  • 资助金额:
    $ 17.64万
  • 项目类别:
Characterisation of skeletal development and the use of anabolic agents in murine models of Duchenne muscular dystrophy
杜氏肌营养不良症小鼠模型中骨骼发育的特征和合成代谢药物的使用
  • 批准号:
    MR/N020588/1
  • 财政年份:
    2016
  • 资助金额:
    $ 17.64万
  • 项目类别:
    Fellowship
Application of effect of low-magnitude and high-frequency loading and bone anabolic agents on peri-implant bone in a osteoporosis model
低强度高频负荷和骨合成代谢药物对种植体周围骨的影响在骨质疏松模型中的应用
  • 批准号:
    15K11148
  • 财政年份:
    2015
  • 资助金额:
    $ 17.64万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
ASSESSMENT OF ANABOLIC AGENTS AND EXERCISE IN BURNED CHILDREN
烧伤儿童的合成代谢药物和运动评估
  • 批准号:
    7952148
  • 财政年份:
    2009
  • 资助金额:
    $ 17.64万
  • 项目类别:
ASSESSMENT OF ANABOLIC AGENTS AND EXERCISE IN BURNED CHILDREN
烧伤儿童的合成代谢药物和运动评估
  • 批准号:
    7719180
  • 财政年份:
    2008
  • 资助金额:
    $ 17.64万
  • 项目类别:
ASSESSMENT OF ANABOLIC AGENTS AND EXERCISE IN BURNED CHILDREN
烧伤儿童的合成代谢药物和运动评估
  • 批准号:
    7605400
  • 财政年份:
    2007
  • 资助金额:
    $ 17.64万
  • 项目类别:
ASSESSMENT OF ANABOLIC AGENTS AND EXERCISE IN BURNED CHILDREN
烧伤儿童的合成代谢药物和运动评估
  • 批准号:
    7378734
  • 财政年份:
    2006
  • 资助金额:
    $ 17.64万
  • 项目类别:
ASSESSMENT OF ANABOLIC AGENTS AND EXERCISE IN BURNED CHILDREN
烧伤儿童的合成代谢药物和运动评估
  • 批准号:
    7202590
  • 财政年份:
    2005
  • 资助金额:
    $ 17.64万
  • 项目类别:
BONE TARGETED DELIVERY OF ANABOLIC AGENTS
合成代谢药物的骨靶向输送
  • 批准号:
    6824532
  • 财政年份:
    2004
  • 资助金额:
    $ 17.64万
  • 项目类别:
BONE TARGETED DELIVERY OF ANABOLIC AGENTS
合成代谢药物的骨靶向输送
  • 批准号:
    7663959
  • 财政年份:
    2004
  • 资助金额:
    $ 17.64万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了